Stem cell therapy may prevent PAD-related amputations

Patients with critical limb ischemia who received injections of stem cells derived from their bone marrow had a lower risk of amputation and death than patients who were not treated with the therapy in a Phase II clinical trial.

View Full Article in:

Stem Cells Improve Outlook for Severe PAD - DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health